GRI Bio (GRI) Cash from Operations (2020 - 2026)
GRI Bio (GRI) posted quarterly Cash from Operations of 3685000.0 for Q1 2026, down 112.27% year-over-year from 30033615.02 in Q1 2025, and down 24.03% quarter-over-quarter from 2971000.0 in Q4 2025.
GRI Bio (GRI) Cash from Operations (2020 - 2026) Analysis & Trends
GRI Bio's Cash from Operations history runs 7 years deep, the most recent figure standing at 3685000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 112.27% year-over-year to 3685000.0; the TTM figure through Mar 2026 stood at 12135000.0 (down 49.01% YoY), while the FY2025 annual figure was 10186000.0, down 18.29% from the prior year.
- Cash from Operations for Q1 2026 stood at 3685000.0, down from 2971000.0 in the prior quarter.
- The five-year high for Cash from Operations was 2174000.0 in Q2 2022, with the low at 5560000.0 in Q4 2023.
- The 5-year median for Cash from Operations is 2141000.0 (2024), against an average of 1915117.65.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations soared 187.24% in 2022, then plunged 948.8% in 2023.
- GRI Bio's Cash from Operations stood at 844000.0 in 2022, then tumbled by 558.77% to 5560000.0 in 2023, then surged by 64.05% to 1999000.0 in 2024, then tumbled by 48.62% to 2971000.0 in 2025, then decreased by 24.03% to 3685000.0 in 2026.
- Business Quant data shows GRI's Cash from Operations at 3685000.0 in Q1 2026, 2971000.0 in Q4 2025, and 2313000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | GRI Bio | 3.01 Mn | 3.01 Mn | - | -1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.69 Mn |
| Mar 31, 2026 | -3.69 Mn |
| Dec 31, 2025 | -2.97 Mn |
| Dec 31, 2025 | -2.97 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Jun 30, 2025 | -3.17 Mn |
| Jun 30, 2025 | -3.17 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.27 Mn |
| Sep 30, 2024 | -2.27 Mn |
| Jun 30, 2024 | -2.14 Mn |
| Jun 30, 2024 | -2.14 Mn |
| Mar 31, 2024 | -2.20 Mn |
| Mar 31, 2024 | -2.20 Mn |
| Dec 31, 2023 | -5.56 Mn |
| Dec 31, 2023 | -5.56 Mn |